IBA Molecular is a global developer, manufacturer and distributor of radiopharmaceutical products and supporting services used in molecular imaging. IBA Molecular has engineered a strong and unique product portfolio and pipeline of diagnostic and therapeutic tracers aimed at advancing the global movement towards personalized medicine and making molecular imaging/therapy a major discipline in healthcare. Founded in 1986, IBA Molecular Spain is jointly owned by SK Capital Partners and IBA (Ion Beam Applications S.A.). The company is a leading manufacturer and distributor of PET and SPECT agents in Europe and Asia, with a network of sites worldwide.